NRXP - NRX Pharmaceuticals Inc

https://www.nrxpharma.com

Recent News

NRx Pharmaceuticals ( NASDAQ:NRXP ) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

GlobeNewswire • 1 week, 5 days ago • score: -0.22

WILMINGTON, Del., Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- NRx Pharmaceuticals, Inc. ( Nasdaq: NRXP ) ( "NRx Pharmaceuticals", or the "Company" ) , a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ( "HOPE," or the "Company" ) , an interventional psychiatry network wholly ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops new treatments for the treatment of life-threatening central nervous system disorders and lung diseases. The company is headquartered in Wilmington, Delaware.

52W High

$6.01

52W Low

$1.10

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.64

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

1.18

EV/EBITDA (<8 favorable)

-0.15

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

2.90

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

11.55%

Institutions (25–75% balanced)

25.47%

Shares Outstanding

23,769,900

Float

13,611,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-2.21

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-6.83%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Value

N/A

Trend

—

Signal Cross

No cross

As of

—